O'Brien TJ, Borghs S, He QJ, Schulz AL, et al. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial. Epilepsia 2020 Mar 28. doi: 10.1111/epi.16484.
PMID: 32221987